FDA Adverse Event Injury Summary report: N

EMBOSPHERE®

MDR report key: 23851855 · Received December 19, 2025

Report

Report Number
1721504-2025-00771
Event Type
Injury
Date Received
December 19, 2025
Date of Event
March 5, 2025
Report Date
December 19, 2025
Manufacturer
BIOSPHERE MEDICAL, S.A.
Product Code
HCG
UDI-DI
00884450402948
PMA / PMN Number
K181300
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IC
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

THE SUSPECT DEVICE WAS NOT RETURNED FOR EVALUATION. THE COMPLAINT COULD NOT BE CONFIRMED. THE ROOT CAUSE COULD NOT BE DETERMINED. A REVIEW OF THE DEVICE HISTORY AND COMPLAINT DATABASE COULD NOT BE PERFORMED SINCE THE LOT NUMBER WAS NOT PROVIDED. NON-CONFORMANCES OF THIS NATURE ARE MONITORED BY THE OPERATION TEAM. THIS COMPLAINT WILL BE USED TO TREND FOR SIMILAR COMPLAINTS.

Description of Event or Problem · 0

A LITERATURE ARTICLE REPORTED POST-EMBOLIZATION SYNDROME, ACUTE TUBULAR NECROSIS, PROSTATITIS, AND URINARY TRACT INFECTION POST EMBOLIZATION USE. NO DEVICE MALFUNCTION IDENTIFIED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
259114 EMBOSPHERE® EMBOLIZATION PARTICLE, NON-BIOABSORBABLE HCG BIOSPHERE MEDICAL, S.A. 00884450402948

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Required Intervention